Progynova
In the US, Progynova is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Breast Cancer - Palliative, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian Failure and Prostate Cancer.
UK matches:
- PROGYNOVA 1MG (Leaflet)
- PROGYNOVA 1MG TABLET (Leaflet)
- PROGYNOVA 1MG TABLETS (Leaflet)
- PROGYNOVA 2MG (Leaflet)
- PROGYNOVA 2MG TABLETS (Leaflet)
Ingredient matches for Progynova
Estradiol is reported as an ingredient of Progynova in the following countries:
- Argentina
- India
Estradiol 17β-valerate (a derivative of Estradiol) is reported as an ingredient of Progynova in the following countries:
- Antigua & Barbuda
- Aruba
- Australia
- Austria
- Bahamas
- Barbados
- Belgium
- Bermuda
- Cayman Islands
- Chile
- China
- Colombia
- Costa Rica
- Dominican Republic
- El Salvador
- Ethiopia
- Finland
- France
- Grenada
- Guatemala
- Guyana
- Honduras
- Hong Kong
- Indonesia
- Israel
- Italy
- Jamaica
- Lithuania
- Luxembourg
- Malaysia
- Malta
- Netherlands
- New Zealand
- Nicaragua
- Norway
- Panama
- Peru
- Philippines
- Russian Federation
- Saint Lucia
- Singapore
- South Africa
- South Korea
- Spain
- Suriname
- Switzerland
- Taiwan
- Thailand
- Trinidad & Tobago
- United Kingdom
- Vietnam
Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Progynova in the following countries:
- United Kingdom
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
